Price Chart

Profile

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
URL https://www.guardanthealth.com
Investor Relations URL https://investors.guardanthealth.com/
HQ State/Province California
Sector Health Care
Industry Health Care Providers & Services
Equity Style Small Cap/Blend
Next Earnings Release Nov. 06, 2024
Last Earnings Release Aug. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
URL https://www.guardanthealth.com
Investor Relations URL https://investors.guardanthealth.com/
HQ State/Province California
Sector Health Care
Industry Health Care Providers & Services
Equity Style Small Cap/Blend
Next Earnings Release Nov. 06, 2024
Last Earnings Release Aug. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A